BACKGROUND: Novel techniques in oncology provide new treatment opportunities but also introduce different patterns of side effects. Intraoperative radiotherapy (IORT) allows a shortened overall treatment time for early breast cancer either combined with whole breast radiotherapy (WBRT), or alone. Although the early side effects of IORT are well known, data on clinically important late side effects, which require medical intervention, are scarce. AIM: In this study, we analyze risk factors for seroma evacuation more than 6 months after IORT. MATERIALS AND METHODS: We evaluated 120 patients with a mean follow-up of 27.8 months (range: 7-52 months). Fifty-one patients received IORT only and 69 were additionally treated with WBRT. RESULTS: Seroma evacuation was performed 6-38 months after IORT. Two (3.9%) events were observed in the IORT group and 14 (20%) in the IORT + WBRT group. Univariate (Kaplan-Meier) analysis showed that addition of WBRT to IORT increased the risk of seroma evacuation [hazard ratio = 5.5, 95% confidence interval: 2.0-14.7, P = 0.011]. In a multivariate analysis (Cox proportional hazards regression), WBRT and axillary lymph node dissection were significant risk factors for seroma evacuation (model P value = 0.0025). CONCLUSIONS: WBRT applied after IORT is associated with increased risk of seroma evacuation, which might be considered as a late side effect.
BACKGROUND: Novel techniques in oncology provide new treatment opportunities but also introduce different patterns of side effects. Intraoperative radiotherapy (IORT) allows a shortened overall treatment time for early breast cancer either combined with whole breast radiotherapy (WBRT), or alone. Although the early side effects of IORT are well known, data on clinically important late side effects, which require medical intervention, are scarce. AIM: In this study, we analyze risk factors for seroma evacuation more than 6 months after IORT. MATERIALS AND METHODS: We evaluated 120 patients with a mean follow-up of 27.8 months (range: 7-52 months). Fifty-one patients received IORT only and 69 were additionally treated with WBRT. RESULTS:Seroma evacuation was performed 6-38 months after IORT. Two (3.9%) events were observed in the IORT group and 14 (20%) in the IORT + WBRT group. Univariate (Kaplan-Meier) analysis showed that addition of WBRT to IORT increased the risk of seroma evacuation [hazard ratio = 5.5, 95% confidence interval: 2.0-14.7, P = 0.011]. In a multivariate analysis (Cox proportional hazards regression), WBRT and axillary lymph node dissection were significant risk factors for seroma evacuation (model P value = 0.0025). CONCLUSIONS: WBRT applied after IORT is associated with increased risk of seroma evacuation, which might be considered as a late side effect.
Entities:
Keywords:
Accelerated partial breast irradiation; Breast cancer; Intraoperative radiotherapy; Seroma; Side effects
Authors: Saskia Litière; Gustavo Werutsky; Ian S Fentiman; Emiel Rutgers; Marie-Rose Christiaens; Erik Van Limbergen; Margreet H A Baaijens; Jan Bogaerts; Harry Bartelink Journal: Lancet Oncol Date: 2012-02-27 Impact factor: 41.316
Authors: Elena Blank; Uta Kraus-Tiefenbacher; Grit Welzel; Anke Keller; Markus Bohrer; Marc Sütterlin; Frederik Wenz Journal: Ann Surg Oncol Date: 2010-09-19 Impact factor: 5.344
Authors: Mohammed R S Keshtgar; Norman R Williams; Max Bulsara; Christobel Saunders; Henrik Flyger; Jaime S Cardoso; Tammy Corica; Neils Bentzon; Nikolaos V Michalopoulos; David J Joseph Journal: Breast Cancer Res Treat Date: 2013-07-23 Impact factor: 4.872
Authors: Benjamin D Smith; Douglas W Arthur; Thomas A Buchholz; Bruce G Haffty; Carol A Hahn; Patricia H Hardenbergh; Thomas B Julian; Lawrence B Marks; Dorin A Todor; Frank A Vicini; Timothy J Whelan; Julia White; Jennifer Y Wo; Jay R Harris Journal: Int J Radiat Oncol Biol Phys Date: 2009-07-15 Impact factor: 7.038
Authors: D H M Jacobs; G Speijer; A L Petoukhova; E M A Roeloffzen; M Straver; A Marinelli; U Fisscher; A G Zwanenburg; J Merkus; C A M Marijnen; M E Mast; P C M Koper Journal: Breast Cancer Res Treat Date: 2018-02-19 Impact factor: 4.872
Authors: Fantine Giap; Lillie O'steen; I-Chia Liu; Lisa E Spiguel; Christiana M Shaw; Christopher G Morris; Raymond B Mailhot Vega; Judith L Lightsey; Julie A Bradley; Nancy P Mendenhall; Paul G Okunieff; Natalie A Lockney Journal: Rep Pract Oncol Radiother Date: 2022-09-19